Bharat Biotech, an Indian pharmaceutical company headquartered in Hyderabad, India, has announced the successful completion of a late-stage trial for its oral cholera vaccine, Hillchol. The company plans to launch the vaccine globally, with the goal of producing up to 200 million doses annually. This development comes at a crucial...
India’s New U.S. Ambassador Assumes Charge
India's former Foreign Secretary, Vinay Mohan Kwatra, assumed charge as the Ambassador of India to the United States. He arrived in the U.S. capital on August 12. Kwatra, 61, succeeds India's former envoy to the United States, Taranjit Singh Sandhu, who retired in January. "Privileged to assume charge as the...
India’s Role in Medical Devices to Blossom with AI Integration
Artificial Intelligence (AI) is being incorporated into various medical devices, including imaging machines for faster scans and lesion detection, wearables for heart arrhythmia detection, and software systems for predicting sepsis risk in hospitals. This trend has prompted regulators to clarify their positions on AI in medical devices. As this happens,...
Bilthoven Biologicals of Netherlands and Bharat Biotech,roduce Polio Vaccines
Hyderabad India-based Bharat Biotech, a major vaccines and bio-therapeutics manufacturer in India, announced a collaboration with Bilthoven Biologicals B.V., the Netherlands-based wholly-owned subsidiary of Serum Institute of India. The partnership aims to strengthen the production and supply security of oral polio vaccines. Polio, or poliomyelitis, is a highly contagious and...
India’s Serum Institute Supplies Covovax to U.S, Malaria Vaccines to U.K.
Earlier this year., India's Drugs Controller General granted permission to Pune Maharashtra-based Serum Institute of India to supply over 32,000 doses of its COVID-19 jab Covovax under the brand name Nuvaxovid to the U.S. Covovax is manufactured through technology transfer from Novavax, an American Company and is approved by the...
Germany Approves Bharat Biotech’s COVAXIN for Travel
German Ambassador to India and Bhutan, Walter J Lindner, announced that the government of Germany recognized WHO-listed Bharat Biotech's Covid vaccine, COVAXIN, for travel to the country starting June 1. In November last year the World Health Organization issued an emergency use listing for Covaxin, adding to a growing portfolio...